ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS

ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS

.

Bibliographic Details
Main Authors:	I. V. Peretokina, L. Yu. Krylova, O. V. Antonova, M. S. Kholina, D. A. Gryadunov, E. Yu. Nosova, D. V. Zimenkov
Format:	Article
Language:	Russian
Published:	Sankt-Peterburg : NIIÈM imeni Pastera 2018-12-01
Series:	Infekciâ i Immunitet
Online Access:	https://www.iimmun.ru/iimm/article/view/1034

Similar Items

A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia.
by: Elena Y Nosova, et al.
Published: (2016-01-01)

Drug susceptibility testing of M. tuberculosis with the help of test system of Sensititre MycoTB TREK Diagnostics
by: M. V. Makarova, et al.
Published: (2015-04-01)

Prevention of resistance to new anti-TB drugs
by: Varudkar H
Published: (2005-01-01)

DETERMINATION OF MINIMAL INHIBITING CONCENTRATIONS OF BEDAQUILINE FOR DRUG SUSCEPTIBILITY TESTING
by: I. V. Peretokina, et al.
Published: (2019-07-01)

MINOR GENETIC DETERMINANTS OF SECOND-LINE INJECTION DRUGS RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
by: R. Jou, et al.
Published: (2018-12-01)

Mechanisms of resistance to new generation anti-TB drugs
by: Visser, Hanri
Published: (2015)

Low levels of anti TB drug resistance in Rayagada district of Odisha, India
by: D Das, et al.
Published: (2014-01-01)

First Line Anti-TB Drug Resistance in an Urban Area of Odisha, India
by: Dasarathi Das, et al.
Published: (2016-11-01)

Resistance to first line anti-TB drugs by gene mutation and gene modulation
by: Louw, Gail Erika
Published: (2009)

The Emergence of Extensively Drug-Resistant Tuberculosis (TB): TB/HIV Coinfection, Multidrug-Resistant TB and the Resulting Public Health Threat from Extensively Drug-Resistant TB, Globally and in Canada
by: Paul E Alexander, et al.
Published: (2007-01-01)

Whole-genome sequencing for TB drug resistance determination
by: S.V. Omar, et al.
Published: (2014-04-01)

Definition of drug resistance of Mycobacterium tuberculosis to antituberculosis drugs in patients with multidrugresistant tuberculosis and TB with extremely drug resistant depending on the case of the disease
by: Kryzhanovsky D.G., et al.
Published: (2014-11-01)

EXPERIENCE OF USING THE TB DRUG OF PERCHLOZON IN TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE IN BURYATIA REPUBLIC
by: S. V. Nikolaeva
Published: (2015-10-01)

Challenges and opportunities in drug-resistant TB
by: G H Cassell
Published: (2015-01-01)

Molecular approaches for detection of the multi-drug resistant tuberculosis (MDR-TB) in Bangladesh.
by: Tafsina Haque Aurin, et al.
Published: (2014-01-01)

Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study
by: Cheng S, et al.
Published: (2021-03-01)

Prevalence of Pre-Extensively Drug-Resistant Tuberculosis (Pre XDR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-TB) among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Center in Mumbai
by: Unnati D. Desai, et al.
Published: (2016-07-01)

Molecular Basis of insulin resistance induced by antiretroviral drugs
by: Ismail, Wan Iryani Wan
Published: (2014)

The molecular basis of antimalarial drug resistance in Plasmodium vivax
by: Lucas E. Buyon, et al.
Published: (2021-08-01)

Molecular Basis for Drug Resistance in HIV-1 Protease
by: Celia A. Schiffer, et al.
Published: (2010-11-01)

Heterogeneity of Mycobacterium tuberculosis drug resistance in respect of pharmacokinetics of anti-tuberculosis drugs as a basis for individual treatment regimen
by: S. A. Popov, et al.
Published: (2015-04-01)

Challenging MDR-TB clinical problems – The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs
by: Simon Tiberi, et al.
Published: (2019-03-01)

XDR-TB, extensively drug-resistant tuberculosis
by: Ernesto Jaramillo
Published: (2007-12-01)

Atripla<sup>R</sup>/anti-TB combination in TB/HIV patients. Drug in focus
by: Semvua Hadija H, et al.
Published: (2011-11-01)

Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold In tube test
by: R. Markova, et al.
Published: (2008-06-01)

Extensively Drug-resistant Tuberculosis (XDR-TB) Raises Challenges in TB Control in Taiwan
by: Wei-Juin Su
Published: (2008-11-01)

Prevalence of tuberculosis with multiple and extensive drug resistance according to the data of Federal register of tb cases
by: V. V. Testov, et al.
Published: (2020-01-01)

Resistance to first-line anti-TB drugs is associated with reduced nitric oxide susceptibility in Mycobacterium tuberculosis.
by: Jonna Idh, et al.
Published: (2012-01-01)

Risk factors for drug resistant TB in British Columbia
by: Moniruzzaman, Akm
Published: (2009)

Relationship between National TB program and prevalence of TB drug resistance in Algeria, 1965 to 2013
by: Fadila Boulahbal
Published: (2015-01-01)

TREATMENT COSTS EVALUATION FOR DRUG SUSCEPTIBLE AND DRUG RESISTANT TUBERCULOSIS PATIENTS IN THE UNITS OF TOMSK REGIONAL TB SERVICES
by: I. E. Gel'manova, et al.
Published: (2016-03-01)

Disseminated multiorgan MDR-TB resistant to virtually all first-line drugs
by: J. Sasse, et al.
Published: (2009-12-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
by: Neeraj Raizada, et al.
Published: (2014-01-01)

Dissecting the molecular basis of PfCRT-mediated antimalarial drug resistance
by: Gabryszewski, Stanislaw J.
Published: (2016)

Defining the role of efflux pump inhibitors on anti-TB drugs in Rifampicin resistant clinical Mycobacterium Tuberculosis isolates
by: Pule, Caroline
Published: (2014)

Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes
by: Yuhui Xu, et al.
Published: (2017-10-01)

Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug
by: Lingaraja Jena, et al.
Published: (2014-01-01)

EFFICIENCY OF INPATIENT TREATMENT OF TUBERCULOSIS PATIENTS WITH DRUG-RESISTANT TB
by: I. F. Kopylova, et al.
Published: (2013-02-01)

Pili in totally drug resistant Mycobacterium Tuberculosis (TDR-TB)
by: Ali Akbar Velayati, et al.
Published: (2012-01-01)